Hospira is a pharmaceutical company that specializes in the development, production, and marketing of generic and biosimilar drugs as well as innovative medical devices. The company's name is derived from the words "hospital" and "inspire," emphasizing its dedication to providing high-quality healthcare products to improve patient outcomes and inspire positive change in the medical industry.
As a generic drug manufacturer, Hospira focuses on producing affordable alternatives to brand-name medications that have already undergone extensive research and development. Generic drugs are identical or bioequivalent to their brand-name counterparts in terms of dosages, administration, safety, and efficacy. By offering generic options, Hospira contributes to increased accessibility of necessary medications worldwide, especially in developing countries where healthcare costs can be prohibitive.
Hospira also specializes in the development of biosimilar drugs, which are highly similar copies of existing biologic drugs. Biologics are complex molecules derived from living organisms and are used to treat various chronic and life-threatening diseases such as cancer and autoimmune disorders. Biosimilars provide more affordable alternatives to these expensive biologic drugs, ensuring that patients have access to life-saving treatments.
Additionally, Hospira manufactures and markets a range of medical devices used in infusion therapy, including infusion pumps. These devices deliver medications and fluids directly into patients' veins, allowing for precise dosage control and continuous monitoring. Hospira's medical devices are designed to enhance patient safety, improve healthcare professionals' workflow, and deliver optimal care.
